Analysis of pazufloxacin mesilate in human plasma and urine by LC with fluorescence and UV detection, and its application to pharmacokinetic study

Chromatographia

Volumn 71, Issue 1-2, 2010, Pages 101-106

  Phapale, Prasad B ^a,b   Lee, Hae Won ^a,b   Kim, Sung Doo ^a,b   Lim, Mi Sun ^a,b   Kale, Dipali D ^a,b   Lee, Ju Mi ^a,b   Park, Jeong Hyeon ^a,b   Moon, Sung Ok ^a,b   Yoon, Young Ran ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Column liquid chromatography; Human plasma and urine; Pazufloxacin; Pharmacokinetics

Indexed keywords

ENOXACIN; PAZUFLOXACIN;

ADULT; ARTICLE; BIOAVAILABILITY; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG URINE LEVEL; FLUORESCENCE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 74149084299     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-009-1408-1     Document Type: Article

References (19)

1. K Yamaki T Hasegawa I Matsuda M Nadai H Aoki K Takagi 1997 J Infect Chemother 3 97 102 10.1007/BF02490182 1:CAS:528:DyaK1cXisFyrtr8%3D
2. Nakashima M, Uematsu T, Kosuge K, Tai M, Nakagawa S, Tsuda H (1992) In: Program and Abstract of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, American Society for Microbiology, abstract 656
3. K Totsuka M Tei K Kodama A Yafune 1996 J Infect Chemother 2 280 282 10.1007/BF02355129
4. H Hayakawa K Takagi YF Takano Y Kawamura A Tsuji 2002 J Pharm Pharmacol 54 9 1229 1236 10.1211/002235702320402071 1:CAS:528:DC%2BD38XotVGgs7w%3D (Pubitemid 35041473)
5. S Zhou J Ouyang W Baeyens H Zhao Y Yang 2006 J Chromatogr A 1130 296 301 10.1016/j.chroma.2006.05.055 1:CAS:528:DC%2BD28XhtVantbzO (Pubitemid 44441312)
6. Y Wang W Baeyens C Huang G Fei L He J Ouyang 2009 Talanta 77 1667 1674 10.1016/j.talanta.2008.10.002 1:CAS:528:DC%2BD1MXpsVegsw%3D%3D
7. Z Zang J Li L Qu R Yang 2008 Chin J Anal Chem 36 7 941 946 10.1016/S1872-2040(08)60050-X
8. J Jin X Zhang 2008 J Lumin 128 81 86 10.1016/j.jlumin.2007.05.008 1:CAS:528:DC%2BD2sXhtVeqsrnK (Pubitemid 47374181)
9. S Chen H Ma H Zhao R Feng L Jin 2004 Anal Sci 20 1075 1078 10.2116/analsci.20.1075 1:CAS:528:DC%2BD2cXlvFKqtrc%3D
10. H Zhang Y Ren X Bao 2009 J Pharm Biomed Anal 49 367 374 10.1016/j.jpba.2008.10.043 1:CAS:528:DC%2BD1MXhs1als7s%3D
11. Q Li R Wang F Pei 2004 Asian J Drug Metab Pharmacokinet 4 289 293
12. C Yang Z Zhang S Chen F Yang 2007 Microchim Acta 159 299 304 10.1007/s00604-007-0758-3 1:CAS:528:DC%2BD2sXosVSltrs%3D
13. Z Zhang G Yang D Wang G Liang Y Chen 2005 J Liq Chromatogr Related Technol 27 813 827 10.1081/JLC-120029700
14. FDA, Guidance for industry, bioanalytical method validation, US Department of Health and Human Services, Center for drug evaluation and research (CDER), 2001; http://www.fda.gov/cder/guidance
15. D Park P Phapale I Jang S Cui B Moon J Kim W Kim S Hwang Y Yoon 2008 Chromatographia 68 187 192 10.1365/s10337-008-0669-4 1:CAS:528: DC%2BD1cXptVertrg%3D
16. KFDA, Guidance for industry, statistical approaches to establishing bioequivalence. Bioequivalence division, Pharmacology department, National institute of toxicology department, 2003; http://eng.kfda.go.kr/index.php
17. FDA Guidance for industry, statistical approaches to establishing bioequivalence. US Department of Health and Human Services, Food and Drug Administration, CDER, 2001; http://www.fda.gov/cder/guidance/index.htm
18. Andriole V (2000) Chemistry and mechanism of action of quinolone antibacterials. In: The Quinolones, 3rd edn. Academic Press, USA, pp 33-96
19. J Kirkland A Straten H Claessens 1998 J Chromatogr A 797 111 120 10.1016/S0021-9673(97)00865-0 1:CAS:528:DyaK1cXhvFKjsbg%3D (Pubitemid 28156953)